Roivant Sciences Ltd. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Roivant Sciences Ltd..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Roivant Sciences Ltd.. Roivant Sciences Ltd. is a 10% Owner in Arbutus Biopharma Corp ($TKMR) and a 10% Owner in Axovant Sciences Ltd. ($AXON) and a 10% Owner in Myovant Sciences Ltd. ($MYOV) and a 10% Owner in Urovant Sciences Ltd. ($UROV).

Over the past year Roivant Sciences Ltd. has been an insider in 3 companies. The total value of shares held by Roivant Sciences Ltd. in these companies amounts to $1,809,171,323.

Roivant Sciences Ltd. 10% Owner
Arbutus Biopharma Corp
10% Owner
Axovant Gene Therapies Ltd.
10% Owner
Myovant Sciences Ltd.
10% Owner
Urovant Sciences Ltd.
$ 1809171323 The total value of shares held by Roivant Sciences Ltd.
Insider Rank

Roivant Sciences Ltd. ranks 64 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM11Bermuda

Companies in which Roivant Sciences Ltd. is an Insider

Arbutus Biopharma Corp

Trading Symbol: TKMR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roivant Sciences Ltd.: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 16 2018
$TKMR Market Capitalization: $138.47M
$TKMR Previous Close: $2.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Axovant Gene Therapies Ltd.

Trading Symbol: AXON
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roivant Sciences Ltd.: 10% Owner
Holdings: 105,952,381 shares
Current Value: $1,374,202,382
Latest Transaction: Mar 19 2019
$AXON Market Capitalization: $1.28B
$AXON Previous Close: $12.97

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 30,952,381
Shares Sold: 0
Share Difference: +30,952,381
Value Difference: -$45,000,000

Myovant Sciences Ltd.

Trading Symbol: MYOV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roivant Sciences Ltd.: 10% Owner
Holdings: 40,765,599 shares
Current Value: $434,968,941
Latest Transaction: Jun 06 2019
$MYOV Market Capitalization: $630.81M
$MYOV Previous Close: $10.67

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,644,272
Shares Sold: 0
Share Difference: +4,644,272
Value Difference: -$65,000,004

Urovant Sciences Ltd.

Trading Symbol: UROV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roivant Sciences Ltd.: 10% Owner
Holdings: 22,848,350 shares
Latest Transaction: Jun 19 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 28x
Sell: 0x
Shares Bought: 5,513,486
Shares Sold: 0
Share Difference: +5,513,486
Value Difference: -$76,247,073

Latest Insider Trading Transactions of Roivant Sciences Ltd.

Sentiment: All, TKMR, AXON, MYOV, UROV

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 19 2019UROVUrovant Sciences L ...Roivant Sciences Ltd.10% OwnerBuyP8.174,95740,49522,860,01322.9 M to 22.9 M (+0.02 %)
Jun 19 2019UROVUrovant Sciences L ...Roivant Sciences Ltd.10% OwnerBuyP8.216,70655,06122,855,05622.8 M to 22.9 M (+0.03 %)
Jun 19 2019UROVUrovant Sciences L ...Roivant Sciences Ltd.10% OwnerBuyP8.536,54155,82522,848,35022.8 M to 22.8 M (+0.03 %)
Jun 14 2019UROVUrovant Sciences L ...Roivant Sciences Ltd.10% OwnerBuyP7.917,14456,51422,841,80922.8 M to 22.8 M (+0.03 %)
Jun 14 2019UROVUrovant Sciences L ...Roivant Sciences Ltd.10% OwnerBuyP7.957,36758,54322,834,66522.8 M to 22.8 M (+0.03 %)
Jun 14 2019UROVUrovant Sciences L ...Roivant Sciences Ltd.10% OwnerBuyP8.307,50062,24422,827,29822.8 M to 22.8 M (+0.03 %)
Jun 11 2019UROVUrovant Sciences L ...Roivant Sciences Ltd.10% OwnerBuyP8.587,18961,69422,819,79822.8 M to 22.8 M (+0.03 %)

View all Roivant Sciences Ltd. insider transactions.